Tacrolimus
- Product NDC
- 70377-014
- 11-digit product format
- 703770014
- Labeler code
- 70377
- Product ID
- 70377-014_640e066c-f2a3-5fb2-4b55-4ac9aec0d31b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tacrolimus
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Biocon Pharma Inc.
- Application
- ANDA212297
- Marketing category
- ANDA
- Marketing start
- 2020-12-23
- Substance
- TACROLIMUS
- Active strength
- .5 mg/1
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tacrolimus
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TACROLIMUS | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WM0HAQ4WNM |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70377-014-11 | Tacrolimus | 100 in 1 BOTTLE | CAPSULE | 100 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70377-014 | TACROLIMUS (TACROLIMUS) CAPSULE [BIOCON PHARMA INC.] | 8 | Current NDC, Legacy NDC, 1 package rows | 20211014_0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70377-014-11 | 70377001411 | 100 CAPSULE in 1 BOTTLE (70377-014-11) | 100 capsule | 2020-12-23 | 0000-00-00 | No | No | Current |